Treatment of laryngeal cancer: The permanent challenge

Expert Review of Anticancer Therapy

Volumn 4, Issue 5, 2004, Pages 913-920

  Lefebvre, Jean Louis ^a   Coche Dequéant, Bernard ^a   Degardin, Marian ^a   Kara, Ahmed ^a   Mallet, Yann ^a   Ton Van, Jean ^a  

^a CENTRE OSCAR LAMBRET   (France)

Author keywords

Chemotherapy; Larynx cancer; Organ preservation; Radiotherapy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; FLUOROURACIL; PLATINUM DERIVATIVE;

ADVANCED CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RESEARCH; CARBON DIOXIDE LASER; CLINICAL PROTOCOL; CLINICAL TRIAL; EARLY CANCER; ENDOSCOPIC SURGERY; EPIDEMIOLOGICAL DATA; HUMAN; INTERMETHOD COMPARISON; LARYNGECTOMY; LARYNX CANCER; LASER SURGERY; MUCOSA INFLAMMATION; OUTCOMES RESEARCH; PATHOLOGICAL ANATOMY; REVIEW; SALVAGE THERAPY; SURGICAL APPROACH; TREATMENT INDICATION; TREATMENT PLANNING; VALIDATION PROCESS;

EID: 5444253225     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.4.5.913     Document Type: Review

References (35)

1. Remacle M, Eckel HE, Antonelli A et al. Endoscopic cordectomy, Proposal for a classification by the Working Committee, European Laryngological Society. Eur. Arch. Otorhinolaryngol. 257, 227-231 (2000).
2. Ambrosch P, Kron M, Steiner W. Carbon dioxide laser microsurgery for early supraglottic carcinoma. Ann. Otol. Rhinol. Laryngol. 107(8), 680-688 (1998).
3. Iro H, Waldfahrer F, Altendorf-Hofmann A. Weidenbrecher M, Sauer R, Steiner W. Transoral laser surgery of supraglottic cancer. Arch. Otolaryngol. Head Neck Surg. 124, 1245-1250 (1998).
4. Rudert HH, Werner JA, Höft S. Transoral carbon dioxide laser resection of supraglottic carcinoma. Ann. Otol. Rhinol. Laryngol. 108, 819-827 (1999).
5. Eckel HH, Thumfart W, Jungehulsing M, Sittel C, Stennert E. Transoral laser surgery for early glottic carcinoma. Eur. Arch. Otorhinolaryngol. 257(4), 221-226 (2000).
6. Peretti G, Nicolai P, Piazza C, Redaelli de Zinis LO, Valentini S, Antonelli AR. Oncological results of endoscopic resection of Tis and T1 glottic carcinomas by carbon dioxide laser. Ann. Otol. Rhinol. Laryngol. 110, 828-825 (2001).
7. 2 laser cordectomy for early-stage glottic carcinoma: a long-term follow-up of 156 cases. Laryngoscope 112(2 , 370-374 (2002).
8. Shvero J, Koren R, Zohar L et al. Laser surgery for the treatment of glottic carcinomas. Am. J. Otolaryngol. 24(1), 28-33 (2003).
9. Pradhan SA, Pai PS, Neeli SI, D'Cruz AK. Transoral laser surgery for early glottic cancers. Arch Otolaryngol. Head Neck Surg. 129(6), 623-625 (2003).
10. Peretti G, Piazza C, Balzanelli C, Cantarella G, Nicoali P. Vocal outcome after endoscopic cordectomies for Tis and T1 glottic carcinomas. Ann Otol. Rhinol. Laryngol. 112, 174-179 (2003).
11. Peretti G, Piazza C, Balzanelli C, Mensi MC, Rossini M, Antonelli AR. Preoperative and postoperative voice in Tis-T1 glottic cancer treated by endoscopic cordectomy: an additional issue for patient counseling. Ann. Otol. Rhinol. Laryngol. 112, 759-763 (2003).
12. Gregoire V, Hamoir M, Rosier JF et al. Cost-minimization analysis of treatment options for T1N0 glottic squamous cell carcinoma: comparison between external radiotherapy, laser microsurgery and partial laryngectomy. Radiother Oncol. 53, 1-13 (1999).
13. Brandenburg JH. Laser cordotomy versus radiotherapy: an objective cost analysis. Ann. Otol. Rhinol. Laryngol. 110, 312-318 (2001).
14. Quer M, Leon X, Orus C, Venegas P, Lopez M, Burgues J. Endoscopic laser surgery in the treatment of radiation failure of early laryngeal carcinoma. Head Neck 22(5), 520-523 (2000).
15. 2-laser treatment for recurrent glottic carcinoma. Head Neck 23(3), 177-180 (2001).
16. 2 laser surgery for carcinoma of the larynx and hypopharynx. Head Neck. 25, 382-388 (2003).
17. Lefebvre JL, Chevalier D. Supracricoid partial laryngectomy In: Advances in Orolaryngology - Head and Neck Surgery, Volume 12. Myers E (Ed.), Mosby, MO, USA, 1-15 (1998).
18. Brasnu DF. Supracricoid partial laryngectomy with cricohyoidopexy in the management of laryngeal carcinoma. World J. Surg. 27(7), 817-823 (2003).
19. Lima RA, Freitas EQ, Kligerman J et al. Supracricoid partial laryngectomy with CHEP: functional results and outcome. Otolaryngol. Head Neck Surg. 124(3), 258-260 (2001).
20. Marioni G, Marchese-Ragona R, Ottaviano G, Staffieri A. Supracricoid partial laryngectomy: is it time to define guidelines to evaluate functional results? A review. Am. J. Otolaryngol. 25(2), 98-104 (2004).
21. Weinstein GS, El-Sawy MM, Ruiz C et al. Laryngeal preservation with supracricoid partial laryngectomy results in improved quality of life when compared with total laryngectomy, Laryngoscope 111(2), 191-199 (2001).
22. Spriano G, Pellini R, Romano G, Muscatello L, Roselli R. Supracricoid partial laryngectomy as salvage surgery after irradiation failure. Head Neck 24(8), 759-765 (2002).
23. Yiotakis J, Stavroulaki P, Nikopoulos T et al. Partial laryngectomy after irradiation failure. Otolaryngol. Head Neck Surg. 128(2), 200-209 (2003).
24. Parsons JT, Mendenhall WM, Stringer SP, Cassisi NJ, Million RR. Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: the University of Florida experience. Head Neck 15(2), 87-95 (1993).
25. Dische S, Saunders M, Barrett A, Harvey A, Gibson D, Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother. Oncol. 44, 123-136 (1997).
26. Le QTX, Fu KK, Kroll S et al. Influence of fraction size, total dose and overall time on local control for T1-T2 glottic carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 39, 115-126 (1997).
27. Fu KK, Pajak TF, Trotti A et al. A radiation Therapy Oncology Group (RTOG) Phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int. J Radiat. Oncol. Biol. Phys. 48(1), 7-16 (2000).
28. Garden AS, Forster F, Wong PF et al. Results of radiotherapy for T2N0 glottic carcinoma: does the '2' stand for twice-daily treatment? Int. J. Radiat. Oncol. Biol. Phys. 55(2), 322-328 (2003).
29. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous cell carcinoma: three meta-analyses of updated individual data. MAHC-NC Collaborative Group. Lancet 355, 949-955 (2000).
30. Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N. Engl. J. Med. 324, 1695-1690 (1991).
31. Richard JM, Sancho-Garnier H, Pessey JJ et al. Randomized trial of induction chemotherapy in larynx carcinoma. Eur. J. Cancer 34, 224-228 (1998).
32. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Shamoud T for the EORTC Head and Neck Cancer Co-operative Group. Larynx preservation in pyriform sinus cancer. Preliminary results of a European Organization for research and Treatment of Cancer Phase III trial. J. Natl Cancer Inst. 88, 890-899 (1996).
33. Laccourreye O, Veivers D, Hans S, Menard M, Brasnu D, Laccourreye H. Chemotherapy alone with curative intent in patients with invasive squamous cell carcinoma of the pharyngolarynx classified as T1-T4N0M0 complete clinical responders. Cancer 92(6), 1504-1511 (2001).
34. Forastiere AA, Goepfert H, Maor M et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N. Engl. J. Med. 349(22), 2091-2098 (2003).
35. Mantz CA, Vokes EE, Kies MS et al. Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. Ann. Oncol. 12(3), 343-347 (2001).